Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy

NCT06680479 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

30

Enrollment

NIH

Sponsor class

Stopped Temporarily Closed (paused)

Conditions

HIV-1

Interventions

BIOLOGICAL: CH505 TF chTrimer
BIOLOGICAL: 3M-052-AF
BIOLOGICAL: Aluminum Hydroxide Suspension
OTHER: Sodium Chloride for Injection

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]